Director Mah Seng Chin of OSR Health, Inc. filed a statement of changes in beneficial ownership on November 19, 2026, disclosing the acquisition of 120,000 shares of common stock on October 29, 2026, at a price of $0 per share under a company incentive plan.

Key Highlights

  • Reporting person: Mah Seng Chin, identified as a Director of OSR Health, Inc. (OTC:OSRH)
  • Transaction date: October 29, 2026, with the filing submitted November 19, 2026
  • Shares acquired: 120,000 shares of OSRH common stock acquired at $0 per share via transaction code A (acquired)
  • Post-transaction ownership: 120,000 shares held directly following the reported transaction
  • Grant basis: According to the filing, the award represents "a fully vested stock award granted under the OSR Health, Inc. 2025 Omnibus Incentive Plan"
  • Lock-up restriction: The filing states the shares "are subject to a six-month contractual lock-up from the grant date"

OSR Health Director Receives Fully Vested Stock Award Under 2025 Incentive Plan

According to the filing, Mah Seng Chin, a director of OSR Health, Inc. (OTC:OSRH), acquired 120,000 shares of OSRH common stock on October 29, 2026, at a stated price of $0 per share. The transaction was coded as an acquisition (code A) in Table I of the filing, which covers non-derivative securities. Following the transaction, the filing reports that Chin directly and beneficially owns 120,000 shares.

The filing's explanation of responses states that the award "represents a fully vested stock award granted under the OSR Health, Inc. 2025 Omnibus Incentive Plan," indicating the shares were issued through a formal equity compensation arrangement established by the company. Despite the shares being fully vested at grant, the filing notes they "are subject to a six-month contractual lock-up from the grant date," meaning the recipient cannot freely transfer or sell them during that period.

The filing was signed by Timothy Clement Smith as Attorney-in-Fact for Seng Chin Mah, dated November 19, 2026, with a Power of Attorney previously filed as Exhibit 24 to the reporting person's Form 3 filed on November 18, 2026. No derivative securities transactions were reported in Table II of this filing.

What Was Disclosed

OSR Health director Mah Seng Chin disclosed the acquisition of 120,000 fully vested shares of OSRH common stock at $0 per share on October 29, 2026, granted under the company's 2025 Omnibus Incentive Plan and subject to a six-month contractual lock-up.